Learning How to Control Biases in Studies to Identify Adverse Effects of Drugs

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2007 Dec 1

PMID 18048712

Citations 3

Authors

Martin Vessey

Affiliations

Soon will be listed here.

Citing Articles

Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Stang P, Ryan P, Overhage J, Schuemie M, Hartzema A, Welebob E Drug Saf. 2013; 36 Suppl 1:S15-25.

PMID: 24166220 DOI: 10.1007/s40264-013-0103-1.

Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history.

Jick H J R Soc Med. 2009; 102(4):160-4.

PMID: 19349509 PMC: 2666051. DOI: 10.1258/jrsm.2009.09k002.

Current awareness: pharmacoepidemiology and drug safety.

Pharmacoepidemiol Drug Saf. 2008; 17(6):i-xvi.

PMID: 18533281 PMC: 7167700.

References

Vessey M, DOLL R . Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J. 1968; 2(5599):199-205. PMC: 1985919. DOI: 10.1136/bmj.2.5599.199. View

Jick H, Jick S, Gurewich V, Myers M, Vasilakis C . Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995; 346(8990):1589-93. DOI: 10.1016/s0140-6736(95)91928-7. View

Daly E, Vessey M, Hawkins M, Carson J, Gough P, Marsh S . Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 1996; 348(9033):977-80. DOI: 10.1016/S0140-6736(96)07113-9. View

Jick H, Vessey M . Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol. 1978; 107(1):1-7. DOI: 10.1093/oxfordjournals.aje.a112502. View

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View